Investors will need patience when investing in Honeywell, but there's plenty of room for improvement, and its long-term outlook is positive. The sum-of-the-parts argument for a breakup is not as ...

Honeywell has failed to deliver the earnings growth necessary to justify a higher stock price. Splitting into three separate companies won’t automatically solve Honeywell’s issues. It could ...

Lung cancer is the leading type of malignant tumour among cancer-caused death worldwide, and the 5-year survival rate of lung cancer patients is only 18%. Various oncogenes are abnormally ...